FlyBase curator comment: this entry represents a transgenic construct where the particular construct used cannot be determined.
Expression of Dcr-1VDRC.cUa driven by Scer\GAL4ple.PF in a heterozygous Dcr-1Q1147X genetic background results in dopaminergic neuron loss and climbing defects.
Adults expressing Dcr-1VDRC.cUa under the control of Scer\GAL4tim.PE have normal locomotor activity rhythms.
Dcr-1RNAi.UAS.cUa, Scer\GAL4ple.PF is an enhancer of abnormal neuroanatomy phenotype of LrrkI1915T.UAS, Scer\GAL4ple.PF
Dcr-1RNAi.UAS.cUa, Scer\GAL4ple.PF is an enhancer of dopaminergic neuron phenotype of LrrkI1915T.UAS, Scer\GAL4ple.PF
In flies expressing LrrkI1915T.Scer\UAS driven by Scer\GAL4ple.PF, Dcr-1VDRC.cUa-overexpression exacerbates the neuronal toxicity of LrrkI1915T.Scer\UAS.
Co-expression of cycScer\UAS.T:Hsim\VP16 and Dcr-1VDRC.cUa under the control of Scer\GAL4tim.PE at 29[o]C results in adults in which the amplitude of the locomotor activity rhythms is dramatically reduced compared to controls.